Marlin

Canaccord Genuity Group Issues Pessimistic Forecast for Ameresco (NYSE:AMRC) Stock Price

01 Mar 2025 11:46:15 By Buzz FX

Oddity Tech (NASDAQ:ODD) Shares Up 6.8% Following Analyst Upgrade

01 Mar 2025 11:46:15 By Buzz FX

Canaccord Genuity Group Issues Pessimistic Forecast for Wallbox (NYSE:WBX) Stock Price

01 Mar 2025 11:46:15 By Buzz FX

JPMorgan Chase & Co. Lowers PTC Therapeutics (NASDAQ:PTCT) Price Target to $72.00

01 Mar 2025 11:46:15 By Buzz FX

Life Time Group (NYSE:LTH) Price Target Raised to $45.00 at Craig Hallum

01 Mar 2025 11:46:15 By Buzz FX

Monster Beverage (NASDAQ:MNST) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

01 Mar 2025 11:46:15 By Buzz FX

Morgan Stanley Forecasts Strong Price Appreciation for Monster Beverage (NASDAQ:MNST) Stock

01 Mar 2025 11:46:15 By Buzz FX

Citigroup Forecasts Strong Price Appreciation for Monster Beverage (NASDAQ:MNST) Stock

01 Mar 2025 11:46:15 By Buzz FX

Randstad (OTCMKTS:RANJY) Short Interest Update | MarketBeat

01 Mar 2025 11:46:15 By Buzz FX

Sekisui House, Ltd. (OTCMKTS:SKHSY) Short Interest Update

01 Mar 2025 11:46:15 By Buzz FX

Canaccord Genuity Group Boosts Privia Health Group (NASDAQ:PRVA) Price Target to $30.00

01 Mar 2025 11:46:15 By Buzz FX

Russia's Central Bank determined to reduce inflation

01 Mar 2025 11:45:24 By Buzz FX

FDI Share in GDP More Than Halved in Two Decades

01 Mar 2025 11:30:25 By Buzz FX

US Fed's inflation gauge cools slightly | The Manila Times

01 Mar 2025 11:15:24 By Buzz FX

KeyCorp Increases Autodesk (NASDAQ:ADSK) Price Target to $335.00

01 Mar 2025 11:06:14 By Buzz FX

ACM Research, Inc. (NASDAQ:ACMR) Given Consensus Recommendation of "Moderate Buy" by Analysts

01 Mar 2025 11:06:14 By Buzz FX

Acushnet (NYSE:GOLF) Price Target Cut to $77.00 by Analysts at KeyCorp

01 Mar 2025 11:06:14 By Buzz FX

KeyCorp Cuts Cable One (NYSE:CABO) Price Target to $650.00

01 Mar 2025 11:06:14 By Buzz FX

Barrington Research Reaffirms "Outperform" Rating for OPKO Health (NASDAQ:OPK)

01 Mar 2025 11:06:14 By Buzz FX

Intellia Therapeutics (NASDAQ:NTLA) Price Target Cut to $68.00 by Analysts at Chardan Capital

01 Mar 2025 11:06:14 By Buzz FX